Header Logo

Connection

Ekihiro Seki to Toll-Like Receptor 7

This is a "connection" page, showing publications Ekihiro Seki has written about Toll-Like Receptor 7.
Connection Strength

0.821
  1. Oral administration of PEGylated TLR7 ligand ameliorates alcohol-associated liver disease via the induction of IL-22. Proc Natl Acad Sci U S A. 2021 01 05; 118(1).
    View in: PubMed
    Score: 0.708
  2. Toll-like receptor 7-mediated type I interferon signaling prevents cholestasis- and hepatotoxin-induced liver fibrosis. Hepatology. 2014 Jul; 60(1):237-49.
    View in: PubMed
    Score: 0.112
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.